Lupin 2024

Emverm

Impax to release Emverm chewable tablets

Impax to release Emverm chewable tablets

HAYWARD, Calif. — Impax Laboratories Inc. has received Food and Drug Administration approval for its supplemental new drug application for Emverm 100-mg chewable tablets, a medication for parasitic worms. Ampex said Friday that Emverm (mebendazole) is indicated for the treatment of pinworm (Enterobius vermicularis), whipworm (Trichuris trichiura), common roundworm (Ascaris lumbricoides), common hookworm (Ancylostoma duodenale)

PP_1170x120_10-25-21